Heron Therapeutics | HRTX - Trade Creditors

Stock Price
1.07
Daily Change
-0.06 -5.31%
Monthly
-15.08%
Yearly
-54.66%
Q1 Forecast
1.15

Heron Therapeutics reported $12.02M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
ALKERMES USD 107.95M 39.95M Dec/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Amarin USD 36.71M 8M Sep/2025
ANI Pharmaceuticals USD 62.58M 7.21M Dec/2025
Anika Therapeutics USD 4.73M 39K Sep/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
Eisai JPY 85.49B 4.76B Dec/2025
Emergent BioSolutions USD 112.2M 500K Dec/2023
Esperion Therapeutics USD 77.51M 2.81M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Heron Therapeutics USD 12.02M 20K Sep/2025
Insmed USD 79.91M 316K Dec/2025
Ligand Pharmaceuticals USD 3.24M 24.52M Dec/2025
Merck USD 4.15B 102M Sep/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Neurocrine Biosciences USD 545.5M 425.6M Dec/2025
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 15.15M 2.54M Dec/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Surmodics USD 2.79M 400K Sep/2024
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Veracyte USD 4.59M 916K Dec/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025